세계의 바이오 임플란트 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Bioimplants Market is presumed to reach the market size of nearly USD 294.5 Billion by 2032 from USD 133.05 Billion in 2023 with a CAGR of 9.23% under the study period 2024-2032.

Bioimplants are medical devices or tissues designed to replace, support, or enhance biological structures or functions within the human body. These implants are made from biocompatible materials such as metals, ceramics, polymers, or biological tissues to minimize immune response and promote integration with surrounding tissues. It serves various purposes, from orthopedic implants for joint replacement and fracture fixation to cardiovascular implants such as stents, pacemakers, heart valves, dental implants, cochlear implants, and cosmetic implants. They offer therapeutic solutions for conditions including trauma, degenerative diseases, congenital abnormalities, and aesthetic enhancements, improving patients' quality of life and functional outcomes.

MARKET DYNAMICS

The escalating prevalence of chronic diseases, musculoskeletal disorders, and age-related conditions such as osteoarthritis and osteoporosis is driving demand for bioimplants as therapeutic solutions for tissue repair, replacement, and regeneration. As the aging population continues to spur globally, there is a growing need for orthopedic implants such as joint replacements, spinal implants, and trauma fixation devices to restore mobility, alleviate pain, and improve quality of life. Additionally, advancements in biomaterials science, tissue engineering, and 3D printing technologies are driving innovation in design and manufacturing, enabling the development of patient-specific implants with enhanced biocompatibility, mechanical properties, and integration with host tissues.

Furthermore, the increasing adoption of minimally invasive surgical techniques and outpatient procedures is expanding the market for bioimplants as alternatives to traditional open surgeries, offering shorter recovery times, reduced hospital stays, and improved patient outcomes. Moreover, the rising healthcare expenditure, expanding access to healthcare services, and growing patient awareness of treatment options are driving market growth in emerging markets. However, potential regulatory hurdles and ethical concerns regarding the use of bioimplants, along with advancements in alternative medical treatments, may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioimplants. The growth and trends of Bioimplants industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Bioimplants market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Cardiovascular Implants
• Orthopedic Implants (Joint Implants, Bone Implants, Soft Tissue Implants)
• Ophthalmic Implants
• Spinal Implants
• Dental Implants
• Breast Implants

By Material Type

• Biomaterial Metal (Titanium, Gold, Silver, Platinum)
• Alloys
• Ceramic
• Polymers

By Application

• Cardiac Surgery
• Trauma And Orthopedic Surgery
• Ophthalmic Surgery
• Neurological Surgery
• Dental Surgery
• Cosmetic And Reconstructive Surgery

By End-Use

• Hospitals
• Specilaty Clinics
• ASCs
• Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Bioimplants market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioimplants market include Abbott Laboratories, Arthrex Inc., Aap Implantate AG, Biotronik SE & Co. KG, Cochlear Ltd., DePuy Synthes (Johnson & Johnson), Edwards Lifesciences Corporation, LifeNet Health, Medtronic Plc, Organogenesis Inc., Smith & Nephew Plc, Stryker Corporation, Zimmer Biomet Holdings Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BIOIMPLANTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Material Type
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-Use
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOIMPLANTS MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Type
• 5.4. Cardiovascular Implants Historic and Forecast Sales By Regions
• 5.5. Orthopedic Implants (Joint Implants, Bone Implants, Soft Tissue Implants) Historic and Forecast Sales By Regions
• 5.6. Ophthalmic Implants Historic and Forecast Sales By Regions
• 5.7. Spinal Implants Historic and Forecast Sales By Regions
• 5.8. Dental Implants Historic and Forecast Sales By Regions
• 5.9. Breast Implants Historic and Forecast Sales By Regions

6. GLOBAL BIOIMPLANTS MARKET ANALYSIS BY MATERIAL TYPE

• 6.1. Overview By Material Type
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Material Type
• 6.4. Biomaterial Metal (Titanium, Gold, Silver, Platinum) Historic and Forecast Sales By Regions
• 6.5. Alloys Historic and Forecast Sales By Regions
• 6.6. Ceramic Historic and Forecast Sales By Regions
• 6.7. Polymers Historic and Forecast Sales By Regions

7. GLOBAL BIOIMPLANTS MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Application
• 7.4. Cardiac Surgery Historic and Forecast Sales By Regions
• 7.5. Trauma And Orthopedic Surgery Historic and Forecast Sales By Regions
• 7.6. Ophthalmic Surgery Historic and Forecast Sales By Regions
• 7.7. Neurological Surgery Historic and Forecast Sales By Regions
• 7.8. Dental Surgery Historic and Forecast Sales By Regions
• 7.9. Cosmetic And Reconstructive Surgery Historic and Forecast Sales By Regions

8. GLOBAL BIOIMPLANTS MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-Use
• 8.2. Historical and Forecast Data
• 8.3. Analysis By End-Use
• 8.4. Hospitals Historic and Forecast Sales By Regions
• 8.5. Specilaty Clinics Historic and Forecast Sales By Regions
• 8.6. ASCs Historic and Forecast Sales By Regions
• 8.7. Other Historic and Forecast Sales By Regions

9. GLOBAL BIOIMPLANTS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BIOIMPLANTS COMPANIES

• 10.1. Bioimplants Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF BIOIMPLANTS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Abbott Laboratories
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Arthrex Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Aap Implantate AG
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Biotronik SE & Co. KG
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Cochlear Ltd.
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. DePuy Synthes (Johnson & Johnson)
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Edwards Lifesciences Corporation
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. LifeNet Health
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Medtronic Plc
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Organogenesis Inc.
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Smith & Nephew Plc
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Stryker Corporation
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. Zimmer Biomet Holdings Inc
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies